Allergic respiratory disease care in the COVID-19 era: A EUFOREA statement.
AIT, allergen-specific immunotherapy
AR, allergic rhinitis
Allergen-specific immunotherapy
Allergy
Asthma
COVID-19
COVID-19, coronavirus disease 2019
Control
EUFOREA, European Forum for Research and Education in Allergy and Airway Diseases
INS, intranasal corticosteroids
NSAID, non-steroidal anti-inflammatory drug
Rhinitis
SAR, seasonal allergic rhinitis
Smell and taste
Symptoms
Treatment
Journal
The World Allergy Organization journal
ISSN: 1939-4551
Titre abrégé: World Allergy Organ J
Pays: United States
ID NLM: 101481283
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
received:
17
04
2020
revised:
28
04
2020
accepted:
07
05
2020
pubmed:
20
5
2020
medline:
20
5
2020
entrez:
20
5
2020
Statut:
epublish
Résumé
Spring and Summer 2020 are unique in that the challenges of care for those suffering from pollen allergy coincide with the COVID-19 pandemic. Several considerations are important to allow optimal care of allergic rhinitis (AR) and asthma and hence prevention of coronavirus spread through sneezing, rhinorrhoea, and coughing. This compact overview of recommendations by the EUFOREA expert teams on allergic airway diseases and allergen-specific immunotherapy (AIT) is based on investigation of the current COVID-19 literature in association with the key words above and shared clinical experience of the experts involved. It deals with similarities and differences between AR and coronavirus infection, specific recommendations for allergic disease care in the COVID-19 era, including guidance on AIT.
Identifiants
pubmed: 32426089
doi: 10.1016/j.waojou.2020.100124
pii: S1939-4551(20)30027-2
pii: 100124
pmc: PMC7229977
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100124Informations de copyright
Crown Copyright © 2020 Published by Elsevier Inc. on behalf of World Allergy Organization.
Références
Allergy Asthma Immunol Res. 2014 Mar;6(2):105-13
pubmed: 24587945
Allergy. 2018 Apr;73(4):765-798
pubmed: 28940458
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422-426
pubmed: 32271728
Eur J Clin Pharmacol. 1986;30(5):625-7
pubmed: 3758151
Int Forum Allergy Rhinol. 2020 Jul;10(7):806-813
pubmed: 32279441
Lancet Respir Med. 2020 May;8(5):436-438
pubmed: 32251625
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Eur Respir J. 2020 May 7;55(5):
pubmed: 32341100
Allergy. 2020 Jul;75(7):1730-1741
pubmed: 32077115
Allergy. 2020 Mar 31;:
pubmed: 32233040
World Allergy Organ J. 2014 Mar 28;7(1):6
pubmed: 24679069
Otolaryngol Head Neck Surg. 1998 May;118(5):648-54
pubmed: 9591864